SMITH IAN F Insider Trading
Get the latest insider transactions of SMITH IAN F. SMITH IAN F is EVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CFO & COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in ACORDA THERAPEUTICS INC ($ACOR) and Director in Ophthotech Corp. ($OPHT) and Director in Solid Biosciences Inc. ($SLDB) and in Foghorn Therapeutics Inc. ($FHTX). Discover the current value of SMITH IAN F shares.
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE 02139MA
SMITH IAN F is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP, COO, EVP, CFO & COO, EVP & CFO, SVP & CFO | 70,074 | 6,085,226.16 |
ACOR | ACORDA THERAPEUTICS INC | Director | 10,000 | 212,000.00 |
INFI | INFINITY PHARMACEUTICALS, INC. | Director | 45,845 | 107,735.75 |
OPHT | IVERIC bio, Inc. | Director | 0 | 0.00 |
SLDB | Solid Biosciences Inc. | Director | 270,270 | |
FHTX | Foghorn Therapeutics Inc. | 0 |
Insider Trading Transactions of SMITH IAN F
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | FHTX | Foghorn Therapeutics Inc. | SMITH IAN F | Option Exercise | 11.50 | 25,060 | 288,190 | 25,060 | |
Jan 06 2021 | SLDB | Solid Biosciences Inc. | SMITH IAN F | Director | Option Exercise | 7.84 | 389,000 | 3,049,760 | 389,000 |
Dec 14 2020 | SLDB | Solid Biosciences Inc. | SMITH IAN F | Director | Buy | 3.70 | 270,270 | 999,999 | 270,270 |
Jun 18 2020 | SLDB | Solid Biosciences Inc. | SMITH IAN F | Director | Option Exercise | 3.03 | 200,000 | 606,000 | 200,000 |
Apr 16 2020 | SLDB | Solid Biosciences Inc. | SMITH IAN F | Director | Option Exercise | 2.49 | 40,000 | 99,600 | 40,000 |
Jul 03 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 131.89 | 23,375 | 3,082,929 | 70,074 |
Jul 03 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 165.22 | 4,741 | 783,308 | 65,333 |
Jul 03 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 166.57 | 18,634 | 3,103,865 | 46,699 |
Jul 03 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 131.89 | 23,375 | 3,082,929 | 10,625 |
Jun 29 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 28.15 | 15,000 | 422,250 | 15,000 |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 109.14 | 4,250 | 463,845 | 50,949 |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 160.00 | 4,250 | 680,000 | 46,699 |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 109.14 | 4,250 | 463,845 | 12,750 |
Jun 19 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 25.45 | 10,000 | 254,500 | 10,000 |
Jun 19 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 13.80 | 15,000 | 207,000 | 25,000 |
Jun 19 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Sell | 31.42 | 25,000 | 785,568 | 0 |
Jun 19 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 25.45 | 10,000 | 254,500 | 0 |
Jun 19 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 13.80 | 15,000 | 207,000 | 0 |
Jun 14 2018 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Buy | 1.75 | 22,857 | 40,000 | 45,845 |
Jun 14 2018 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.75 | 20,000 | 35,000 | 20,000 |
Jun 14 2018 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.75 | 4,000 | 7,000 | 4,000 |
May 16 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 155.78 | 217 | 33,804 | 46,699 |
May 04 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 20.16 | 10,000 | 201,600 | 10,000 |
May 04 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Sell | 23.46 | 3,677 | 86,277 | 6,323 |
May 04 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Sell | 23.86 | 6,323 | 150,897 | 0 |
May 04 2018 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 20.16 | 10,000 | 201,600 | 0 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 0.00 | 15,170 | 0 | 56,058 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 0.00 | 8,437 | 0 | 64,495 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 155.57 | 19,566 | 3,043,883 | 19,566 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 96.87 | 2,125 | 205,849 | 43,013 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 155.80 | 825 | 128,535 | 42,188 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 157.02 | 400 | 62,808 | 41,788 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 158.11 | 400 | 63,244 | 41,388 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 159.29 | 500 | 79,645 | 40,888 |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 96.87 | 2,125 | 205,849 | 4,250 |
Nov 17 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 147.29 | 7 | 1,031 | 40,888 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 91.05 | 2,155 | 196,213 | 43,043 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 150.00 | 2,155 | 323,250 | 40,888 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 77.31 | 4,250 | 328,568 | 45,138 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 150.00 | 4,250 | 637,500 | 40,888 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 91.05 | 2,155 | 196,213 | 19,397 |
Nov 07 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 77.31 | 4,250 | 328,568 | 4,250 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 142.40 | 1,700 | 242,080 | 114,188 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 143.47 | 5,200 | 746,044 | 108,988 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 144.47 | 32,945 | 4,759,564 | 76,043 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 145.26 | 22,464 | 3,263,121 | 53,579 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 146.39 | 5,200 | 761,228 | 48,379 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 147.40 | 3,500 | 515,900 | 44,879 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 148.26 | 3,791 | 562,054 | 41,088 |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 149.34 | 200 | 29,868 | 40,888 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Buy | 96.87 | 2,125 | 205,849 | 118,013 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 154.01 | 200 | 30,802 | 117,813 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 155.03 | 875 | 135,651 | 116,938 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 156.24 | 850 | 132,804 | 116,088 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Sell | 157.07 | 200 | 31,414 | 115,888 |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, COO | Option Exercise | 96.87 | 2,125 | 205,849 | 6,375 |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 77.31 | 4,250 | 328,568 | 120,138 |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 154.09 | 400 | 61,636 | 119,738 |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 155.29 | 2,600 | 403,754 | 117,138 |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 156.02 | 1,250 | 195,025 | 115,888 |
Aug 09 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 77.31 | 4,250 | 328,568 | 8,500 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 91.05 | 2,155 | 196,213 | 118,043 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 152.49 | 500 | 76,245 | 117,543 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 153.57 | 500 | 76,785 | 117,043 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 154.55 | 700 | 108,185 | 116,343 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 156.09 | 455 | 71,021 | 115,888 |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 91.05 | 2,155 | 196,213 | 21,552 |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 83.36 | 2,125 | 177,140 | 118,013 |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 152.24 | 925 | 140,822 | 117,088 |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 153.30 | 1,100 | 168,630 | 115,988 |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 154.13 | 100 | 15,413 | 115,888 |
Aug 02 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 83.36 | 2,125 | 177,140 | 0 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 96.87 | 25,500 | 2,470,185 | 151,738 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 91.05 | 10,775 | 981,064 | 162,513 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 77.31 | 55,250 | 4,271,378 | 217,763 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 83.36 | 31,875 | 2,657,100 | 249,638 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 161.00 | 123,400 | 19,867,400 | 126,238 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 157.56 | 400 | 63,024 | 125,838 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 158.62 | 1,829 | 290,116 | 124,009 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 159.61 | 815 | 130,082 | 123,194 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 161.01 | 2,000 | 322,020 | 121,194 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 161.71 | 5,106 | 825,691 | 116,088 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 162.40 | 200 | 32,480 | 115,888 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 96.87 | 25,500 | 2,470,185 | 8,500 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 91.05 | 10,775 | 981,064 | 23,707 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 77.31 | 55,250 | 4,271,378 | 12,750 |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 83.36 | 31,875 | 2,657,100 | 2,125 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 45.11 | 37,383 | 1,686,347 | 163,621 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 48.74 | 18,124 | 883,364 | 181,745 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 37.86 | 23,789 | 900,652 | 205,534 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 51.75 | 9,062 | 468,959 | 214,596 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Buy | 38.80 | 10,195 | 395,566 | 224,791 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 124.00 | 98,553 | 12,220,572 | 126,238 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 45.11 | 37,383 | 1,686,347 | 0 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 48.74 | 18,124 | 883,364 | 0 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 37.86 | 23,789 | 900,652 | 0 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 51.75 | 9,062 | 468,959 | 0 |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | 38.80 | 10,195 | 395,566 | 0 |
Jun 02 2017 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 13.80 | 15,000 | 207,000 | 15,000 |
May 26 2017 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Buy | 1.74 | 22,988 | 39,999 | 22,988 |
May 26 2017 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.74 | 20,000 | 34,800 | 20,000 |
May 26 2017 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.74 | 4,000 | 6,960 | 4,000 |
May 17 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 114.92 | 294 | 33,786 | 126,238 |
Feb 15 2017 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP, CFO & COO | Sell | 87.66 | 3,842 | 336,790 | 130,080 |
Jan 09 2017 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.46 | 40,000 | 58,400 | 40,000 |
Aug 04 2016 | OPHT | Ophthotech Corp. | SMITH IAN F | Director | Option Exercise | 62.63 | 20,000 | 1,252,600 | 20,000 |
Jun 21 2016 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.52 | 20,000 | 30,400 | 20,000 |
Jun 21 2016 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 1.52 | 4,000 | 6,080 | 4,000 |
Jun 10 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 27.93 | 15,000 | 418,950 | 15,000 |
May 18 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 82.06 | 202 | 16,576 | 112,999 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 17,299 | 173 | 125,083 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 89.90 | 5,000 | 449,500 | 120,083 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 90.97 | 4,232 | 384,985 | 115,851 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 91.68 | 1,200 | 110,016 | 114,651 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 92.73 | 1,652 | 153,190 | 112,999 |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 91.05 | 34,482 | 3,139,586 | 34,482 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 22.13 | 542 | 11,994 | 542 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 17.85 | 2,689 | 47,999 | 3,231 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Buy | 18.21 | 10,000 | 182,100 | 13,231 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Sell | 41.85 | 13,131 | 549,480 | 100 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Sell | 42.26 | 100 | 4,226 | 0 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 22.13 | 542 | 11,994 | 0 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 17.85 | 2,689 | 47,999 | 0 |
Jan 06 2016 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 18.21 | 10,000 | 182,100 | 0 |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 124.95 | 2,800 | 349,860 | 115,334 |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 125.98 | 4,865 | 612,893 | 110,469 |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 126.62 | 2,685 | 339,975 | 107,784 |
Jul 23 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 131.89 | 34,000 | 4,484,260 | 34,000 |
Jun 16 2015 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 11.06 | 15,000 | 165,900 | 15,000 |
Jun 16 2015 | INFI | INFINITY PHARMACEUTICALS, ... | SMITH IAN F | Director | Option Exercise | 11.06 | 4,000 | 44,240 | 4,000 |
Jun 11 2015 | ACOR | ACORDA THERAPEUTICS INC | SMITH IAN F | Director | Option Exercise | 30.49 | 15,000 | 457,350 | 15,000 |
May 18 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 123.85 | 100 | 12,385 | 118,412 |
May 18 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 125.84 | 178 | 22,400 | 118,234 |
May 18 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 126.99 | 100 | 12,699 | 118,134 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 122.44 | 200 | 24,488 | 123,976 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 123.52 | 200 | 24,704 | 123,776 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 124.87 | 1,327 | 165,702 | 122,449 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 125.69 | 2,815 | 353,817 | 119,634 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 126.65 | 1,000 | 126,650 | 118,634 |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 127.83 | 500 | 63,915 | 118,134 |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 12,084 | 121 | 39,877 |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 38.80 | 54,375 | 2,109,750 | 54,375 |
Jan 26 2011 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 40.71 | 6,042 | 245,970 | 27,793 |
Jan 25 2011 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 39.93 | 6,042 | 241,257 | 33,835 |
Nov 16 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 34.47 | 77 | 2,654 | 39,877 |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 33.82 | 36,250 | 1,225,975 | 36,250 |
May 19 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 37.68 | 774 | 29,164 | 39,877 |
May 10 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 35.72 | 5,869 | 209,641 | 49,008 |
May 10 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 36.16 | 9,131 | 330,177 | 39,877 |
Apr 06 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 40.75 | 18,242 | 743,362 | 54,877 |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 12,084 | 121 | 73,119 |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 39.05 | 90,625 | 3,538,906 | 90,625 |
Oct 26 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 33.00 | 300,000 | 9,900,000 | 300,000 |
Jul 20 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 33.28 | 36,250 | 1,206,400 | 36,250 |
May 19 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 28.44 | 925 | 26,307 | 61,035 |
May 11 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 28.90 | 32,500 | 939,250 | 61,035 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 7,349 | 114,644 | 100,884 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 11.27 | 18,000 | 202,860 | 118,884 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 10.41 | 15,863 | 165,134 | 134,747 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 35.00 | 41,212 | 1,442,420 | 93,535 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.60 | 7,349 | 114,644 | 0 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 11.27 | 18,000 | 202,860 | 0 |
Feb 10 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 10.41 | 15,863 | 165,134 | 6,187 |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 33.51 | 2,376 | 79,620 | 81,925 |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 34.11 | 474 | 16,168 | 81,451 |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 12,084 | 121 | 93,535 |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 33.55 | 54,375 | 1,824,281 | 54,375 |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 26.18 | 16 | 419 | 84,301 |
Jul 25 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 32.16 | 36,250 | 1,165,800 | 36,250 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 26.20 | 19,075 | 499,765 | 103,376 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 24.66 | 5,000 | 123,300 | 108,376 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.87 | 4,821 | 76,509 | 113,197 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 3,715 | 57,954 | 116,912 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 9.07 | 14,400 | 130,608 | 131,312 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 9.69 | 21,600 | 209,304 | 152,912 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 10.41 | 2,700 | 28,107 | 155,612 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 17.16 | 10,125 | 173,745 | 165,737 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 35.00 | 81,436 | 2,850,260 | 84,301 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 26.20 | 19,075 | 499,765 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 24.66 | 5,000 | 123,300 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.87 | 4,821 | 76,509 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.60 | 3,715 | 57,954 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 9.07 | 14,400 | 130,608 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 9.69 | 21,600 | 209,304 | 0 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 10.41 | 2,700 | 28,107 | 22,050 |
Jul 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 17.16 | 10,125 | 173,745 | 7,875 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.48 | 93 | 2,556 | 85,138 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.59 | 93 | 2,566 | 85,045 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.61 | 186 | 5,135 | 84,859 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.71 | 93 | 2,577 | 84,766 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.47 | 93 | 2,555 | 84,673 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.54 | 93 | 2,561 | 84,580 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.64 | 93 | 2,571 | 84,487 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.66 | 93 | 2,572 | 84,394 |
May 22 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.94 | 93 | 2,598 | 84,301 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 26.99 | 50 | 1,350 | 89,981 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.00 | 475 | 12,825 | 89,506 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.03 | 75 | 2,027 | 89,431 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.07 | 150 | 4,061 | 89,281 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.11 | 580 | 15,724 | 88,701 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.20 | 70 | 1,904 | 88,631 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.26 | 50 | 1,363 | 88,581 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.46 | 100 | 2,746 | 88,481 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.70 | 80 | 2,216 | 88,401 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.01 | 400 | 10,804 | 88,001 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.02 | 200 | 5,404 | 87,801 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.04 | 400 | 10,816 | 87,401 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.05 | 500 | 13,525 | 86,901 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.09 | 300 | 8,127 | 86,601 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.10 | 478 | 12,954 | 86,123 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.10 | 300 | 8,130 | 85,823 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.15 | 500 | 13,575 | 85,323 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.16 | 200 | 5,432 | 85,123 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.19 | 322 | 8,755 | 84,801 |
May 15 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 27.41 | 500 | 13,705 | 84,301 |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 9,667 | 97 | 90,031 |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 18.93 | 36,250 | 686,213 | 36,250 |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 26.20 | 90,925 | 2,382,235 | 171,039 |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 40.00 | 90,925 | 3,637,000 | 80,114 |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 26.20 | 90,925 | 2,382,235 | 0 |
Jul 16 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 28.84 | 36,250 | 1,045,450 | 36,250 |
May 21 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 31.95 | 823 | 26,295 | 80,114 |
May 08 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 30.61 | 32,500 | 994,825 | 80,114 |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 12,084 | 121 | 92,614 |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 0.01 | 20,000 | 200 | 112,614 |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 36.30 | 54,375 | 1,973,813 | 54,375 |
Dec 14 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 38.55 | 480 | 18,504 | 80,530 |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.87 | 1,607 | 25,503 | 82,617 |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 2,213 | 34,523 | 84,830 |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 33.65 | 3,820 | 128,543 | 81,010 |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.87 | 1,607 | 25,503 | 339,598 |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.60 | 2,213 | 34,523 | 337,385 |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.87 | 1,607 | 25,503 | 82,617 |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 2,213 | 34,523 | 84,830 |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 34.96 | 3,820 | 133,547 | 81,010 |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.87 | 1,607 | 25,503 | 343,418 |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.60 | 2,213 | 34,523 | 341,205 |
Jul 24 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 35.35 | 36,250 | 1,281,438 | 345,025 |
May 18 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 31.47 | 1,965 | 61,839 | 81,010 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.87 | 1,607 | 25,503 | 82,617 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 38.31 | 1,607 | 61,564 | 81,010 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 2,213 | 34,523 | 83,223 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 38.31 | 2,213 | 84,780 | 81,010 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.87 | 1,607 | 25,503 | 310,988 |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.60 | 2,213 | 34,523 | 308,775 |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.87 | 5,222 | 82,873 | 86,232 |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 37.81 | 5,222 | 197,444 | 81,010 |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Buy | 15.60 | 6,086 | 94,942 | 87,096 |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Sell | 37.81 | 6,086 | 230,112 | 81,010 |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTICALS IN ... | SMITH IAN F | EVP & CFO | Option Exercise | 15.87 | 5,222 | 82,873 | 318,681 |